Please provide your email address to receive an email when new articles are posted on . Eyes with the insert had significantly less corneal and conjunctival staining at week 4, the latter of which ...
Please provide your email address to receive an email when new articles are posted on . Researchers reported improvements at 1 month in OSDI scores, corneal fluorescein staining, and conjunctival ...
A research team demonstrated non-invasive imaging of conjunctival goblet cells (CGCs) in live rabbit eyes for the diagnosis of ocular surface diseases including dry eye disease (DED). A Korean ...
The key to diagnosing and managing dry eye syndrome (DES) lies in staging the condition with proven tools, addressing the patient's symptoms, and using evidence-based approaches to treatment. This is ...
LONDON and NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of ...
ISTA Pharmaceuticals Reports Results From the Second of Two Studies in the REMURA(TM) Phase 3 Clinical Program for Dry Eye Disease IRVINE, CA, Oct 13, 2011 (MARKETWIRE via COMTEX) -- ISTA ...
IRVINE, Calif., June 8 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) , today announced positive results from a proof-of-concept Phase 2 clinical ...
Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye. This was a phase 4, single-arm, multicenter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback